October 2024
Congratulations to Viola! Our collaboration with the Ding group at DTU Bioengineering is out in Nat. Commun. Alligamycin A is a new antifungal natural product isolated from a Streptomyces strain.
September 2024
We are recruiting a postdoc in organic synthesis and carbohydrate chemistry. Deadline is October 15. Read more and apply here!
Congratulations to Peng! Our article describing a polysaccharide vaccine for S. Pneumonia is out in Commun. Biol. Thanks to all co-authors for a great collaboration. Read the open access article here!
August 2024
Welcome to Román Sainz! He joins the group as a postdoc in collaboration with the Gotfredsen group and NMR Center DTU. He will work on FBDD and RNA targeting.
We have two openings for PhD positions as part of the TargetRNA doctoral network. See all the positions here and the specific positions in the groups here: DC2 and DC3. There is a mobility requirement for the positions – apply before September 15 through JobNorge.
Mads was visiting BOKU in Vienna, presenting recent results from the group. It was a pleasure to catch up with Prof. Fabian Pfrengle and discuss ongoing scientific projects with members of his team!
July 2024
Congratulations to Cecilia et al. Our cancer vaccine technology is finally out in RSC Med. Chem. Great collaboration with Croda Pharma, the Goletz group at DTU Bioengineering, and DTU Health Technology. Read the open access article here!
Congratulations to Cecilia! Our collaboration with the Pfrengle group at BOKU on GT arrays is out in Chem. Comm. Cecilia’s RG-I backbone heptasaccharide played a key role in characterizing a plant rhamnosyl transferase – stay tuned for the exciting chemistry, soon to appear on ChemRxiv!
June 2024
We are grateful to the European Commission for supporting the COFUND program INTERdisciplinary MSCA ACTion for HEALTH (INTERACT). We look forward to the collaboration with the University of Copenhagen and to bridge technical, basic, and clinical science
We are grateful to the Novo Nordisk Foundation for supporting the application SHARPSYN - Sharpening synthetic chemical tools by targeting Nature’s most complex glycan through the NERD program. The grant will allow us to supercharge our activities in synthetic method development, oligosaccharide synthesis, and plant cell wall biology. Look out for positions announced over the coming months and years.
Welcome to Natalia Skinder. She joins the group as a postdoctoral fellow, working on our carbohydrate-based vaccine technologies.
George and Mads were in Zaragoza for the first conference of the GlyCanDrug network.
Cláudia and Mads were in Oxford for the annual general assembly of the Fragment-Screen project.
Mads will be in Miami, visiting project partners in the TNFR project.
May 2024
Welcome to George Lasisi. He joins the group for his PhD with in the GlyCanDrug doctoral network. He will work on the identification of inhibitors of glycosyl transferases.
Mads will present our vaccine technology for infectious disease at the DTU Microbes Initiative Conference 2024.
Mads will share recent results from the group at the Spring symposium of the Center for Medicinal Chemistry at the University of Copenhagen on May 30. See the full program here.
April 2024
Mads will be in Berlin for the kickoff of the IMPULSE project. We look forward to the collaboration with EU-OPENSCREEN ERIC and the Brenk group at the University of Bergen on new technologies.
We are grateful to the European Commission for the invitation to initiate grant agreement negotiations for the TargetRNA project. We look forward to collaborating with the University of Bergen, Goethe University Frankfurt and the other partners.
March 2024
Kasper successfully defended his PhD on March 22. Thanks to the committee: Prof. Teresa Carlomagno, Prof. Anders Bach, and Assoc. Prof. Sebastian Meier for an inspiring discussion of the thesis.
The 2024 bakeoff is underway.
Welcome to Rebekka Riis. She joins the group for her PhD in collaboration with Prof. Jan Ardenkjær-Larsen at DTU Healthtech. Rebekka will be working on synthesis of radical enhancers for Hyperpolarized Magnetic Resonance.
We are grateful to the DTU PoC fund for their continued belief in our epilepsy project. We look forward to continue the pursuit of better treatment options.
February 2024
Welcome to Yevhenii Sokolenko. He joins the group as a postdoc working on PROTAC development.
Welcome to Yann Duchesne, who joins the group for his MSc thesis project. He will work with Cláudia in the FBDD team.
Welcome to Jimmy Liang, who joins the group for his BSc thesis research.
January 2024
We are recruiting a postdoc in vaccine development, immunology, and cell biology. Deadline is February 15. Read more and apply here!
Drug Discovery Today has a feature on a decade of achievements by the European Lead Factory. We are proud of our contributions to the design and synthesis of the academic compound library in ELF.
The group will be well represented at the Torkil Holm Symposium 2024.
Welcome back to Ahmad Haidar. He joins the group for his PhD studies in collaboration with Prof. Jan Ardenkjær-Larsen at DTU Healthtech. Ahmad will be working on synthesis of enhancers for Hyperpolarized Magnetic Resonance.
The 2nd meeting in the Danish Society for Carbohydrate Chemistry took place in Aarhus on January 18. Thanks to all the participants for a great meeting – and a special thanks to Carmen Galan, who shared recent results from her lab in Bristol.
Congratulation to Cecilia, who was awarded the prize for best talk by an early-stage researcher!
December 2023
Peng will defend his PhD thesis on December 18. Thanks to the committee: Prof. Cristina Nativi, Head of Global Research and Development Dennis Christensen, and Prof. Jens Duus.
We are grateful to SPARK Denmark for supporting our vaccine development research and for including us in the SPARK cohort 3. We look forward to participating in the program over the next two years!
Congratulations to Claudia who won the MHC bake-off competition. It was very well deserved!
November 2023
The 1st GlycoNoVi workshop takes place in beautiful Siena, Italy. Dileep will present his research plan and meet the rest of the project partners.
We are grateful to the DTU PoC Fund for supporting our vaccine development program for pneumonia.
October 2023
We are recruiting a postdoc in medicinal chemistry and NMR spectroscopy. Deadline is November 15. Read more and apply here!
Welcome to Isabella Romeo. She joins the group as a postdoc working in the FBDD team.
Congratulations to Silvia, who successfully defended her MSc thesis.
Welcome to Myrto Prifti. She joins the group as an Erasmus scholar, working with Cláudia in the FBDD team.
Our MHC bake off competition continues. The category was Halloween cakes.
September 2023
Faranak and Mads will be in Germany for a triple header: the EU-OPENSCREEN Drive annual meeting, the bi-annual Partner Site Forum, and the 12th Assembly of Members. Busy days in Berlin ahead!
Welcome to Dileep Paladugu. He joins the group for his PhD in oligosaccharide synthesis in the GlycoNoVi doctoral network in collaboration with Glycom/DSM.
August 2023
We are recruiting a PhD student in chemical biology of glycosyl transferases. The project will focus on the identification of small molecule inhibitors of sialyl and fucosyltransferases and include training in chemical synthesis of reagents, assay development, miniaturization and automation for high-throughput screening (HTS). The application deadline is September 1. More info about the project and application here.
A two-and-a-half-year postdoc position is available in our group. The project will involve design and synthesis of PROTACs for mitogen-activated protein kinases (MAPKs). Deadline is September 7. More info here.
Mads will be at the ACS meeting in San Francisco. He will present recent research from the group on Sunday, August 13 in the CARB/POLY symposium Advances in Glycomaterials for Biomimicry and Biomedicine.
July 2023
Cecilia and Mads will be at Eurocarb21 in Paris, presenting recent results from the group.
June 2023
Cecilia and Mads will be at the Carbohydrates GRC in New Hampshire, USA, presenting recent results from the group.
Our monthly MHC bake off competition. The category was biscuits.
The group participated in the annual DTU 3 x 5 km relay race! The boss is again taking the picture – he would never miss a good run!
May 2023
We are grateful to the Independent Research Fund Denmark for supporting our project on developing selective degraders of the mitogen-activated protein kinases (MAPKs). We look forward to pursuing this exciting avenue of research and to collaborate further with the Cuenda group at CSIC Madrid.
Our monthly MHC bake off competition. The category was raw/no-bake cakes.
Mads will attend the ELRIG´s Therapeutic OLIGOs & European Chemical Biology Symposium 2023 in Gothenburg, Sweden.
Welcome to Thomas Sidobre from ENSCMu, who joins the group for a research internship.
April 2023
Faranak and Mads will be in Berlin for the EU-OPENSCREEN AoM11.
Welcome to Susanne Rasmussen who joins the DTU Screening Core as technician specializing in cell biology.
Welcome to Elsa Albertelli from ENSICAEN, who joins the group for a research internship.
Congratulations to Henri. Our review of small-molecule modulators of TNF signaling is online in Drug Disc. Today. Thanks to Dilip, Katrine, Charlotte, Roberta, Michael and Anders for a great collaboration with the Universities of Copenhagen and Miami.
Our monthly MHC bake off competition. The category was fruit-based cakes.
A two-year postdoc position in medicinal chemistry is available. Deadline is June 1.
March 2023
EU provides grants for cutting-edge cancer research through canSERV. A first of its kind, the largest European-wide consortium of research infrastructures is offering free-of-charge transnational access to state-of-the-art services to develop breakthrough personalised cancer treatments. More info here. The application deadline is April 25.
Our monthly MHC bake off competition. The category was vegan cakes.
Cláudia will be in Frankfurt for the Fragment-Screen kickoff meeting.
Mads will travel to Tokyo to participate in the 103rd Chemical Society of Japan Annual Meeting and present recent results from the group.
Welcome to Giulia Baldoni who joins the group for her MSc project as an ERASMUS student. Giulia will join the immuno-oncology team.
Congratulation to Shadi. After one year’s internship in the group he very successfully defended his final project and is now a laboratory technician.
February 2023
The GlycoNoVi project is starting and we look forward to the collaboration with Glycom – DSM and the other partners. You can read about the project here. We are recruiting a PhD student in synthetic carbohydrate chemistry. If you are interested in oligosaccharide synthesis and want to get hands-on industry experience at Glycom, please have a look at the DC4 description. The application deadline is April 16.
Our very first MHC bake off competition. The category was pies.
Welcome to Dr. Cláudia Braga. She joins the FBDD team as a postdoctoral fellow.
We are grateful to the EU Commission for supporting Fragment-Screen. The project aims to develop innovative instrumentation, workflows and experimental and computational methodologies to accelerate the development of new pharmaceuticals using the approach of fragment-based drug discovery (FBDD).
Welcome to Sebastian Helboe Empacher, who joins the group for a one-year traineeship as laboratory technician.
January 2023
Welcome back to Silvia Pastor, who will carry out her MSc thesis research in the group in the spring.
Welcome to Christine Duedahl-Olesen, who joins the group for her BSc thesis research.
The group will be at the January 27 Symposium organized by the Danish Society for Medicinal Chemistry and Chemical Biology. Strong lineup of speakers as well as poster presentations of cutting-edge research.
Mads talks about our immuno-oncology project on the “Vov at vide” podcast. Listen here (in Danish). Thanks to the Independent Research Fund Denmark for supporting the research and the podcast.
View News before 2023